Carregant...
Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
PURPOSE: Filgrastim, a recombinant human granulocyte-colony stimulating factor, is widely used to treat congenital and acquired neutropenia. Following patent expiration of the innovator filgrastim product, biosimilar filgrastim products have been approved in the EU and shown to be comparable with th...
Guardat en:
| Publicat a: | Pharm Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182392/ https://ncbi.nlm.nih.gov/pubmed/30280277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-018-2491-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|